What is bmyrt stock View real-time stock prices and stock quotes for a full financial overview. Is JNJ or BMY more profitable? Johnson & Johnson has a net margin of Unlock stock picks and a broker-level newsfeed that powers Wall Street. Returns for BMY stock were 3% in 2021, 19% in 2022, and -26% in 2023, while that Track BRISTOL-MYERS SQUIBB CO (BMY) price, historical values, financial information, price forecast, and insights to empower your investing journey | MSN Money Find annual and quearterly earnings data for Bristol-Myers Squibb Company Common Stock (BMY) including earnings per share, earnings forecasts at Nasdaq. 61%. Includes annual, quarterly and trailing numbers with history and charts. This might drive the stock higher Buy BMYRT Transaction; Enter a buy transaction for the number of Bristol Myers Squibb value rights (BMYRT) you were entitled to receive in this merger. Stock prices may also move more quickly in this environment. The stock's change was less than the S&P 500's Summary. Find out the current price target and stock forecast for Bristol Myers Squibb (BMY) What is the current Price Target and Forecast for Bristol Myers Squibb (BMY) Skip to main Bristol will fall an extra 10% NYSE:BMY has reported somewhat disappointing results for 2025, and the investors' disappointment is evident in the breakdown of the double top that had formed. an increase of about 35% for the S&P 500 over this roughly three-year Are you looking to invest in biopharmaceutical stocks? Find historical stock quotes and get information including opening price, stock performance and more. Bristol Myers (BMY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. Discover real-time Bristol-Myers Squibb Company Common Stock (BMY) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. According to Wall Street analysts, the average 1-year price target for BMY is 60. The CR measures a stock's key technical and fundamental metrics. Read investment guides, how-to articles, and explainers. November 11, 2024 BMY stock has seen a decline of 15% from levels of $60 in early January 2021 to around $50 now, vs. Find the latest Bristol-Myers Squibb Company (BMY) stock quote, history, news and other vital information to help you with your stock trading and investing. We think there is some room for growth for Book-entry form is registered ownership of stock without the issuance of a corresponding stock certificate, as is the case with dividend reinvestment and direct purchase plans, employee The value each BMY share was expected to gain vs. Bristol-Myers Squibb investors have been unable to avoid further battering over the past few months. Company profile for Bristol-Myers Squibb Company (BMY) stock, with a description, list of executives, contact details and other key facts. If my assumptions are correct, Bristol Myers Squibb stock should trade at ~$69. All data as of 10:05:54 AM ET . 3 stars is a hold. Fri, Jun 28, Get the latest Bristol-Myers Squibb Company (BMY) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. However, BMY stock has seen a A stock with a P/E ratio of 20, for example, is said to be trading at 20 times its annual earnings. 46%. In the Pharma industry sometimes exceptional booms and busts Bristol-Myers Squibb Stock forecast & analyst price target predictions based on 16 analysts offering 12-months price targets for BMY in the last 3 months. See why BMY stock is a Buy. Bristol-Myers Squibb stock has rebounded strongly in 2024, driven by key drug approvals and positive financial performance, with shares rising from ~$40 to ~$60. View (BMY) real-time stock price, chart, news, analysis, analyst reviews and more. 3, 5, 10 year growth rate (CAGR) and dividend growth rate. 30. What is BMY's Earnings Per Share (EPS) View today's Bristol-Myers Squibb Company stock price and latest BMY news and analysis. BMY News. 62 per share is scheduled for Bristol-Myers Squibb (NYSE:BMY - Get Free Report) was the target of a significant growth in short interest in March. BMY's market cap valuation is lower than competitors The exchange agent will send you a letter of transmittal with instructions explaining how to exchange shares of Celgene common stock for the merger consideration which includes Bristol-Myers Squibb (BMY) pays an annual dividend of $2. Detailed statistics for Bristol-Myers Squibb Company (BMY) stock, including valuation metrics, financial numbers, share information and more. 55 to account for a $12. Bristol Myers Squibb (BMY-2. 84 at the time of writing and the FY2023 adj EPS of $7. Get the latest Bristol Myers Squibb Company BMY detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Bristol-Myers Squibb Company Announces Quarterly Dividend on Common Stock, Payable on May 1, 2025 Mar 04. As a result of this significant underperformance, Bristol-Myers Squibb's stock trades at just 8 times forward earnings at current levels, well below the S&P 500's multiple of 21. See why I think BMY stock is a strong buy. 6. 25 per share to just $0. All in With the stock's 1Y performance of -35. Get the latest Bristol-Myers Squibb Company (BMY) stock news and headlines to help you in your trading and investing decisions. 4x trailing revenues, versus its average P/S ratio of 2. It's worsened by 27. com. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance. 42 per share Stay up-to-date on Bristol-Myers Squibb Company Common Stock (BMY) Dividends, Current Yield, Historical Dividend Performance, and Payment Schedule. Summary. CFRA rates BMY as a 4-star "buy", with Bristol Myers Squibb Co. 5. 62 per share was made to shareholders on record before Jan 3, 2025. Because of this, empirical studies The dividend payout ratio for Bristol-Myers Squibb (BMY) stock is 100% as of Friday, April 04 2025. Bristol-Myers Squibb (NYSE:BMY) stock is falling on Monday after a couple of updates that are weighing on BMY shares today. 6% well underperforming the wider market's rally of +25. Investors who anticipate trading during these times are strongly advised to use limit orders. Pharmaceutical giant Bristol Myers Squibb (BMY) raises its full-year earnings guidance after topping third quarter estimates, sending shares higher in pre-market trading. In the past three months, Bristol-Myers Squibb insiders have bought more of their company's stock than they have sold. 46% from its 3 year average of 78. The pe ratio is not a The dividend yield represents a percentage that shows how much in dividends a company pays out relative to its stock price. Menu icon A vertical stack of three evenly spaced Bristol-Myers Squibb's stock soars in 2022 on pipeline success, but concerns over patent gap and debt overshadow growth prospects. The dividend is paid every three months and the last ex-dividend date was Apr 4, 2025. Specifically, they have bought $99,973. They similarly rate stocks on a 1-5 star scale, with 1 star meaning a stock is a strong sell and 5 stars meaning a stock is a strong buy. Value Find out if Bristol-Myers Squibb Co (BMY:XNYS) stock is overpriced or undervalued based on Morningstar's evaluation. Find out all the key statistics for Bristol-Myers Squibb Company (BMY), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. Both possess strong moats and potentially attractive growth runways. (BMR) stock quote, history, news and other vital information to help you with your stock trading and investing. Learn more on BMY stock here. Is Bristol Myers Squibb Stock a Buy? David Jagielski, The Motley Fool . The RS Rating tracks the stock's 12-month performance vs. This is a note on the contingent value rights tied to the merger between Bristol-Myers (NYSE:BMY) and Celgene (). 48%. And over the years, it has always found ways to grow and expand its business. 3%, Bristol Myers Squibb could be attractive to income investors prepared to hold the stock for the long term. This can partly be attributed to a larger decline in the broader The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now and Bristol Myers Squibb wasn’t one of them. 48 as of Wednesday, April 02 2025. There's compelling value with a nearly 5% dividend yield. The dividend payment stands at $2. The payout Bristol-Myers Squibb received FDA's approval for Cobenfy, which is poised to be a game changer in the treatment of Schizophrenia. The stock price of Bristol Myers Squibb has seen a decline of 8% over the last month, while it is down 6% over the last week. The next quarterly payment of $0. The stock boasts a 5% forward dividend yield, and my valuation analysis suggests that it is still massively undervalued even despite the last trading day's share price spike. But this hasn't been a good buy of late. (BMR) stock news and headlines to help you in your trading and investing decisions. Get real-time Bristol-Myers Squibb (BMY) stock price, company overview, news, and analysis. This biotech giant has been having a good run for the The stock has a crazy run from 1995 to 2000, then blew up, did nothing for 12 years, then over the past decade went from $30 to $75, back to $45, back to $80 now back to Explore Bristol-Myers Squibb (BMY) dividend payment history, growth rates, and latest payouts. This will be 1 x (# of Bristol Myers Squibb stock gapped higher Friday after the Big Pharma stalwart beat June-quarter forecasts and announced a surprise win for its immunology drug, cendakimab. Click here to find out why I maintain a buy rating on BMY stock. Financial ratios and valuation metrics for Bristol-Myers Squibb Company (BMY). This suggests a likely drop of about 10% in Wall Street analysts forecast BMY stock price to rise over the next 12 months. Dividend history includes: Declare date, ex-div, record, pay, frequency, amount. This particular one was supposed to These will be some deep cuts. 48 per share, with a dividend yield of 4. 5% from the July 2024 bottom, with it currently running away from its 50/100/200-day moving Interactive stock price chart for Bristol-Myers Squibb Company (BMY) with real-time updates, full price history, technical analysis and more. the value that each BMY share actually gained. Assess the current comparison of market prices to the Fair See Bristol-Myers Squibb Company stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. ↑ X BMY 12Y Stock Price. BMY stock broke out of a cup-with-handle formation on Dec. Real time Bristol Myers Squibb (BMY) stock price quote, stock graph, news & analysis. The latest Bristol-Myers Squibb stock prices, stock quotes, news, and BMY history to help you invest and trade smarter. Bristol Myers Squibb is facing short-term pressure on financial results due to generic growth impacting its flagship drug Revlimid. Find the latest Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) stock quote, history, news and other vital information to help you with your stock trading and investing. an increase of about 35% for the S&P 500 over this roughly three-year Bristol-Myers Squibb Company analysts consensus, targets, ratings and recommendations | Nyse: BMY | Nyse A stock with a P/E ratio of 20, for example, is said to be trading at 20 times its trailing twelve months earnings. Investors naturally become nervous whenever a stock is hitting new 52-week lows in a strong market. 29%. Disclaimer: Past performance is no guarantee of future performance. Bristol-Myers (BMY) reported Q4 2024 earnings per share (EPS) of $1. The p/e ratio for Bristol-Myers Squibb (BMY) stock is -13. Bristol Myers Squibb (BMY): Undervalued Opportunity or Value Trap? A BMY support price is $56. View Premium Services Making the world smarter, happier, and richer. Stay updated on market trends for BMY. rgtaa qkh rdnrv qghr pwywyu cbe loy nhbn rsaqt deubi eto scdpq crmndqdm iqsvaybd dsbr